Normal functionality and inactive joint inflammation after five years of etanercept therapy in rheumatoid arthritis patients with early and long-standing disease

被引：0
|
作者：
Bathon, JM
Moreland, LW
Genovese, MC
Baumgartner, SW
Fleischmann, RM
Weinblatt, ME
Whitmore, JB
White, B
Leff, JA
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[4] Phys Clin Spokane, Spokane, WA USA
[5] Radiant Res, Dallas, TX USA
[6] Brigham & Womens Hosp, Boston, MA 02115 USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [31] Pregnancies in Patients with Long-Standing Rheumatoid Arthritis and Biologic DMARD Treatment: Course of Disease during Pregnancy and Pregnancy Outcomes
    Strangfeld, Anja
    Pattloch, Dagmar
    Spilka, Madlen
    Manger, Bernhard
    Krummel-Lorenz, Brigitte
    Graessler, Annett
    Listing, Joachim
    Zink, Angela
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
    Cruyssen, Bert Vander
    Van Looy, Stijn
    Wyns, Bart
    Westhovens, Rene
    Durez, Patrick
    Van den Bosch, Filip
    Mielants, Herman
    De Clerck, Luc
    Peretz, Ann
    Malaise, Michel
    Verbruggen, Leon
    Vastesaeger, Nathan
    Geldhof, Anja
    Boullart, Luc
    De Keyser, Filip
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
  • [33] Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
    Bert Vander Cruyssen
    Stijn Van Looy
    Bart Wyns
    Rene Westhovens
    Patrick Durez
    Filip Van den Bosch
    Herman Mielants
    Luc De Clerck
    Ann Peretz
    Michel Malaise
    Leon Verbruggen
    Nathan Vastesaeger
    Anja Geldhof
    Luc Boullart
    Filip De Keyser
    Arthritis Research & Therapy, 8
  • [34] The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis
    Harrison, MJ
    Tricker, KJ
    Davies, L
    Hassell, A
    Dawes, P
    Scott, DL
    Knight, S
    Davis, M
    Mulherin, D
    Symmons, DPM
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (12) : 2330 - 2336
  • [35] Structural damage is not a major driver of disease impact in patients with long-standing psoriatic arthritis undergoing systemic therapy
    Queiro, Ruben
    Pino, Marina
    Charca, Lilyan
    JOINT BONE SPINE, 2021, 88 (02)
  • [36] ONE YEAR RESULTS OF "TREAT TO TARGET" STRATEGY IN PATIENTS WITH EARLY AND LONG-STANDING RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: THE REMARCA TRIAL
    Karateev, D.
    Luchikhina, E.
    Demidova, N.
    Lukina, G.
    Kanonirova, M.
    Mouraviev, Y.
    Olyunin, Y.
    Gridneva, G.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 235 - 236
  • [37] Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity
    Bert Vander Cruyssen
    Patrick Durez
    Rene Westhovens
    Filip De Keyser
    Arthritis Research & Therapy, 12
  • [38] Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity
    Vander Cruyssen, Bert
    Durez, Patrick
    Westhovens, Rene
    De Keyser, Filip
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [39] IS THE EXTENT OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER FIVE YEARS OF FOLLOW-UP ASSOCIATED WITH MARKERS OF INFLAMMATION?
    Sodergren, A.
    Ruge, T.
    Karp, K.
    Smedby, T.
    Moller, B.
    Rantapaa-Dahlqvist, S.
    Wallberg-Jonsson, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 608 - 609
  • [40] Twelve years survival after COBRA combination therapy in patients with early rheumatoid arthritis.
    van Tuyl, Lilian H. D.
    Voskuyl, Alexandre E.
    Lems, Willem F.
    Dijkmans, Ben A. C.
    Boers, Maarten
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S240 - S240
12345